Harvey Brian Nicholas — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Harvey Brian Nicholas is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Brian Nicholas Harvey is the Chief Financial Officer of Adicet Bio, Inc., as listed in the company's SEC filing dated January 27, 2026. In this role, he oversees financial strategy, corporate finance, and capital planning for Adicet Bio, a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies, including the ADI-001 program.
Role
Insider
Notability
45/100
Board memberships
Adicet Bio, Inc.
Awards & honors
Oversees financial strategy and capital planning for Adicet Bio, guiding budgeting and financial reporting in a publicly traded biotech.
Brian Nicholas Harvey is the Chief Financial Officer of Adicet Bio, Inc., as listed in the company's SEC filing dated January 27, 2026. In this role, he oversees financial strategy, corporate finance, and capital planning for Adicet Bio, a clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies, including the ADI-001 program.…
Where can I see all of Harvey Brian Nicholas's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
